DONATION FROM NEUROCRINE BIOSCIENCES, INC. FOR INGREZZA.PDF

RESOLUTION: 
  
NEUROCRINE BIOSCIENCES, INC. INGREZZA MEDICATIONS 
 
WHEREAS, an average of 10 CHS patients per year are prescribed Ingrezza for the treatment of Tardive Dyskinesia. 
Annually, CHS has administered an average of 40 prescriptions per year for this medication, which represents a total 
medication cost of approximately $285,000; 
 
WHEREAS, recent medical literature indicates Tardive dyskinesia is a challenging and often irreversible side effect 
associated with the use of antipsychotic medications, significantly affecting various aspects of an individual's life. Historically, 
the primary course of action was to discontinue the medication in question, with the outcome largely left to chance. In cases 
where discontinuation was not feasible due to severe mental illness, psychiatrists conveyed to patients that they would need 
to manage the side effects without further options. However, the introduction of Vesicular Monoamine Transporter 2 (VMAT-
2) inhibitors, such as Ingrezza, has transformed the treatment landscape, with many patients experiencing significant 
improvements in their condition. VMAT-2 inhibitors enable psychiatrists to maintain effective treatment with robust 
psychotropic medications while enhancing patient functionality and overall quality of life; 
 
WHEREAS, partnering with Neurocrine Biosciences to receive Ingrezza free of charge, Maricopa County CHS will be able 
to continue these treatments on stable patients and initiate therapy on candidates who may benefit the most; 
 
NOW THEREFORE:  
 
BE IT RESOLVED, The Board of Supervisors will adopt this Resolution and authorize Maricopa County, through its 
Department of CHS, to complete a non-financial Certification and Request form with Neurocrine Biosciences, Inc. for free 
samples of the following: 
 
From Neurocrine Biosciences, Inc. 
o 
Ingrezza® in 40mg, 60mg, and 80mg doses 
  
  
Dated this ____12th_____ day of _________October________________, 2024.  
  
  
For and Behalf of Maricopa County   
  
  
  
By___________________________  
    Chairman, Board of Supervisors   
  
 
___________________________ 
Date  
Attest:  
  
  
  
___________________________  
Clerk of the Board   
  
 
___________________________ 
Date   
Approved as to form:                         
  
  
  
___________________________ 
Deputy County Attorney  
  
 
____________________________ 
Date  
 
Docusign Envelope ID: 26F81A6C-3419-424F-9B09-F62DE2471CE0
10/3/2024